Browse Category

NASDAQ:HRMY News 13 January 2026

Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion

Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion

NEW YORK, Jan 13, 2026, 16:19 EST — After-hours Shares of Harmony Biosciences Holdings Inc (HRMY) slid 6.4% on Tuesday to close at $35.82, after trading as low as $34.69. The move comes as investors work through a pipeline reshuffle and a new revenue outlook that landed just as healthcare executives crowd into San Francisco for the annual J.P. Morgan…

Stock Market Today

  • Advanced Braking Technology Limited Shares Rally 33% with High Yet Justifiable P/E Ratio
    January 23, 2026, 3:25 PM EST. Advanced Braking Technology Limited (ASX:ABV) shares surged 33% recently, marking a 56% rise in the past year. Despite a high price-to-earnings (P/E) ratio of 31.3, above the Australian average of 21, investors remain confident due to strong earnings growth. The company's earnings per share (EPS) rose 163% over three years, with a projected 29% annual EPS increase over the next three years, surpassing the market's 17% forecast. This robust earnings outlook supports the elevated P/E ratio, indicating investors expect continued growth rather than overvaluation. Analyst confidence underscores the market's positive sentiment toward ABV's future performance amid a solid last fiscal year showing.
Go toTop